tldrdailynews.com logo

CRISPR Pioneer Launches Startup to Advance Personalized Gene-Editing Therapies

1 min read
Source: Fierce Biotech
CRISPR Pioneer Launches Startup to Advance Personalized Gene-Editing Therapies
Photo: Fierce Biotech
TL;DR

Menlo Ventures has invested $16 million in Aurora Therapeutics, co-founded by CRISPR pioneer Jennifer Doudna and Fyodor Urnov, to develop personalized CRISPR therapies targeting rare diseases like PKU, leveraging recent regulatory and technological advances to make treatments for ultra-rare conditions more feasible.

Topics:businesshealthcare#aurora-therapeutics#crispr#healthcare#menlo-ventures#personalized-medicine#rare-diseases
Share this article
  1. Baby KJ scientist launches personalized CRISPR therapy startup  Fierce Biotech
  2. Key scientist from Baby KJ team launches startup to scale personalized CRISPR medicines  statnews.com
  3. A new CRISPR startup is betting regulators will ease up on gene-editing  MIT Technology Review
  4. Aurora sets out to capitalize on FDA’s new framework for bespoke drug therapies  BioPharma Dive
  5. Crispr Pioneer Launches Startup to Make Tailored Gene-Editing Treatments  WIRED

Want the full story? Read the original reporting

Read on Fierce Biotech